Histone deacetylase inhibitor abexinostat affects chromatin organization and gene transcription in normal B cells and in mantle cell lymphoma
Abstract
No abstract availableKeywords
Funding Information
- Laboratoires Servier (PHA78454 014)
This publication has 64 references indexed in Scilit:
- Decreased Expression of Proapoptotic Genes Caspase-8- and BCL2-Associated Agonist of Cell Death (BAD) in Ovarian CancerClinical Ovarian and Other Gynecologic Cancer, 2014
- Perinucleolar relocalization and nucleolin as crucial events in the transcriptional activation of key genes in mantle cell lymphomaBlood, 2014
- Emerging agents for the treatment of mantle cell lymphomaExpert Review of Anticancer Therapy, 2012
- Rationale for Targeting CD6 as a Treatment for Autoimmune DiseasesArthritis, 2010
- PCI-24781 Induces Caspase and Reactive Oxygen Species–Dependent Apoptosis Through NF-κB Mechanisms and Is Synergistic with Bortezomib in Lymphoma CellsClinical Cancer Research, 2009
- Association of GSTP1 expression with resistance to docetaxel and paclitaxel in human breast cancersEuropean Journal of Surgical Oncology, 2008
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- Molecular characterization of the tumor microenvironment in breast cancerCancer Cell, 2004
- High Level of Glutathione- S -Transferase π Expression in Mantle Cell LymphomasClinical Cancer Research, 2004
- ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalancesBlood, 2002